Showing results (11-20 of 87) with videos related to
Sort By:
Pageof 9
Experientia|March 15, 1982
The prevention of alloxan-induced diabetes in mice by the iron-chelator detapac: suggestion of a role for iron in the cytotoxic processR E Heikkila, F S CabbatLife Sciences|February 21, 1983
Studies on the stability of 3H-dopamine in neostriatal membrane preparations: effects of Ascorbic acidR E Heikkila, F S CabbatEuropean Journal of Pharmacology|November 1, 1978
Protection against alloxan-induced diabetes in mice by the hydroxyl radical scavenger dimethylureaR E Heikkila, E S CabbatProgress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1988
Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and methamphetamine in several strains of miceP K Sonsalla, R E HeikkilaNeuroscience Letters|June 4, 1985
1-Methyl-4-phenylpyridine (MPP+) is toxic to mesencephalic dopamine neurons in cultureC Mytilineou, G Cohen, R E HeikkilaJournal of Neurochemistry|May 1, 1986
Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridiniumI Vyas, R E Heikkila, W J NicklasThe Journal of Biological Chemistry|April 10, 1976
In vivo inhibition of superoxide dismutase in mice by diethyldithiocarbamateR E Heikkila, F S Cabbat, G CohenNeurology|November 1, 1983
Behavioral correlations of dopamine receptor activationO Gershanik, R E Heikkila, R C DuvoisinNeurology|December 1, 1982
Pergolide-induced circling in rats with 6-hydroxydopamine lesions in the nigrostriatal pathwayR C Duvoisin, R E Heikkila, L ManzinoThe Journal of Pharmacology and Experimental Therapeutics|October 1, 1989
Attenuation by dopamine uptake blockers of the inhibitory effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and some of its analogs on NADH-linked metabolism in mouse neostriatal slicesS Ofori, R E Heikkila, W J NicklasPageof 9